Evidence map›Paper›PMID 30180178›Full record

ArticlePloS one2018

Software tools for cell culture-related 3D printed structures.

Marton Gulyas, Miklos Csiszer, Elod Mehes, Andras Czirok

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Viscoelastic Properties of ECM-Rich Embryonic Microenvironments.Frontiers in cell and developmental biology · 2020
    Article
  11. Software for Bioprinting.International journal of bioprinting · 2020
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marton GulyasDepartment of Biological Physics, Eotvos University, Budapest, Hungary.ORCID 0000-0001-7253-8537
Miklos CsiszerDepartment of Biological Physics, Eotvos University, Budapest, Hungary.
Elod MehesDepartment of Biological Physics, Eotvos University, Budapest, Hungary.
Andras CzirokDepartment of Biological Physics, Eotvos University, Budapest, Hungary.

Funding

Morphogenetic Tissue Movements in Early EmbryosR01GM102801 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CZIROK, ANDRAS · 2014 to 2017
$1.1M
NIGMS NIH HHS R01 GM102801
6 · The paper itself

Abstract

Three-dimensional (3D) printing technology allowed fast and cheap prototype fabrication in numerous segments of industry and it also became an increasingly versatile experimental platform in life sciences. Yet, general purpose software tools to control printer hardware are often suboptimal for bioprinting applications. Here we report a package of open source software tools that we developed specifically to meet bioprinting requirements: Machine movements can be (i) precisely specified using high level programming languages, and (ii) easily distributed across a batch of tissue culture dishes. To demonstrate the utility of the reported technique, we present custom fabricated, biocompatible 3D-printed plastic structures that can control cell spreading area or medium volume, and exhibit excellent optical properties even at 50 ul sample volumes. We expect our software tools to be helpful not only to manufacture customized in vitro experimental chambers, but for applications involving printing cells and extracellular matrices as well.

Indexed as

Printing, Three-DimensionalSoftware3T3 CellsAnimalsBiocompatible MaterialsBioprintingCell Culture TechniquesCell LineExtracellular MatrixHumansMaterials TestingMiceOptical PhenomenaBiocompatible Materials

Identifiers

PMID30180178
PMCPMC6122815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.